CRISPR Based Technologies and Bio-products

Genome editing and the utilization of CRISPR primarily based technologies are expected to revolutionize the assembly of the next generation of bio products. DCB12 can focus on the most recent developments within the use of CRISPR/Cas9 and alternative CRISPR primarily based technologies in reference to the development and production of biopharmaceuticals, biochemicals, agricultural crops and travel applications.

    Related Conference of CRISPR Based Technologies and Bio-products

    July 19-20, 2021

    25th Global Congress on Biotechnology

    Geneva, Switzerland
    August 06-07, 2021

    International Conference on Plant Genomics

    London, UK
    August 13-14, 2021

    36th International Conference on Immunology & Immunogenetics

    Edinburgh, Scotland
    September 13-14, 2021

    4th Annual Summit on Cell and Gene Therapy

    Prague, Czech Republic
    September 22-23, 2021

    13th World Congress on Cell and Stem Cell Research

    Madrid, Spain
    September 27-28, 2021

    15th International Conference on Genomics & Pharmacogenomics

    Vancouver, Canada
    October 18-19, 2021

    20th International Conference on Structural Biology

    Rome, Italy
    November 20-21, 2021

    26th World Congress on Industrial Biotechnology

    Chicago, USA
    December 07-08, 2021

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 09-10, 2021

    2nd International Conference on Geriatrics and Ageing

    Sydney, Australia

    CRISPR Based Technologies and Bio-products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in